康恩贝艾司奥美拉唑镁肠溶胶囊获药品注册证书

Core Viewpoint - Kang En Bei announced that its wholly-owned subsidiary, Zhejiang Jinhua Kang En Bei Biopharmaceutical Co., Ltd., has received the drug registration certificate for Esomeprazole Magnesium Enteric-coated Capsules in 20mg and 40mg specifications from the National Medical Products Administration [1] Group 1: Product Information - Esomeprazole Magnesium Enteric-coated Capsules (Nexium) is the first proton pump inhibitor developed by AstraZeneca that contains a single optical isomer [1] - Nexium was launched in the United States in 2001 and approved for entry into China in 2007, effectively inhibiting gastric acid secretion [1] - The drug is primarily used for treating gastroesophageal reflux disease, erosive reflux esophagitis, and in combination with appropriate antibiotics to eradicate Helicobacter pylori, promoting the healing of related peptic ulcers [1]